Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) with a low cure rate. Periplaneta americana is a traditional American Cockroach and reportedly has potential therapeutic roles for UC treatment; however, its mechanisms remain unclear. To address this, we investigated the therapeutic effects and underlying molecular mechanisms of Ento-A, a Periplaneta americana extract, in a dextran sulfate sodium (DSS)-induced chronic and recurrent UC mouse model. Ento-A treatment decreased pro-inflammatory cytokine secretion, disease activity index (DAI), colon mucosa damage index (CMDI), histopathological scores (HS), and increased colon length. Additionally, Ento-A effectively increased interleukin-4 (IL-4), and forkhead transcription factor protein 3 (Foxp3) expression levels, while it abated interferon-γ (IFN-γ) and IL-17 levels in spleen lymphocytes. Conversely, in mesenteric lymph nodes, IL-4 and Foxp3 expression were decreased, while IFN-γ and IL-17 expression was increased. Furthermore, Ento-A blocked p-PI3K, p-AKT,*and p-NF-κB activation. In conclusion, Ento-A improved UC symptoms and exerted therapeutic effects by regulating immune responses and inhibiting PI3K/AKT/NF-κB signaling.
Similar content being viewed by others
Data availability
All data generated or analyzed in this study are included in this manuscript and supplementary data.
References
Actis GC, Pellicano R, Rosina F (2015) Inflammatory bowel disease: traditional knowledge holds the seeds for the future. World J Gastrointest Pharmacol Ther 6:10–16
Adedara IA, Ajayi BO, Awogbindin IO, Farombi EO (2017) Interactive effects of ethanol on ulcerative colitis and its associated testicular dysfunction in pubertal BALB/c mice. Alcohol 64:65–75
Bai HF, Li YP, Qin FY, Yan YM, Wang SM, Zhang HX, Cheng YX (2020) Periplanetols A-F, phenolic compounds from Periplaneta americana with potent COX-2 inhibitory activity. Fitoterapia 143:104589
Carbonnel F, Jantchou P, Monnet E, Cosnes J (2009) Environmental risk factors in Crohn’s disease and ulcerative colitis: an update. Gastroenterol Clin Biol 33(Suppl 3):S145-157
Che Y-H, Yang Z-B, Zhang H-C, Wu X-M, Sun M-Z, Tang M, Wang P-C, Geng F-N, Wan P, Liu HJ (2020) Study on the effect of Periplaneta americana on ulcerative colitis in rats induced by 2, 4, 6-trinitrobenzene sulfonic acid. Eur J Inflammation 18:2058739220942629
Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F (2005) Regulatory T cells and intestinal homeostasis. Immunol Rev 204:184–194
Domenech E, Vega R, Ojanguren I, Hernandez A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabre E, Gassull MA (2008) Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 14:1373–1379
Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336
Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, Yang ZQ, Exley M, Kitani A, Blumberg RS, Mannon P, Strober W (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113:1490–1497
Gao JY, Jiang YL, Niu LL, Li HD, Yin WP (2016) Novel Isoflavone from the Cockroach Periplaneta americana. Chem Nat Compd 52:413–416
Goyal A, Wang Y, Graham MM, Doseff AI, Bhatt NY, Marsh CB (2002) Monocyte survival factors induce Akt activation and suppress caspase-3. Am J Respir Cell Mol Biol 26:224–230
Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB (2004) Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 279:1615–1620
Huang XL, Xu J, Zhang XH, Qiu BY, Peng L, Zhang M, Gan HT (2011) PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. Inflamm Res 60:727–734
Ilan Y (2016) Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clin Transl Immunol 5:e60
Kappelman MD, Moore KR, Allen JK, Cook SF (2013) Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 58:519–525
Kim DS, Kim SJ, Kim MC, Jeon YD, Um JY, Hong SH (2012) The therapeutic effect of chelidonic acid on ulcerative colitis. Biol Pharm Bull 35:666–671
Kornbluth A, Sachar DB (2004) Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 99:1371–1385
Latella G, Viscido A (2020) Controversial contribution of Th17/IL-17 toward the immune response in intestinal fibrosis. Digest Dis Sci 65:1299–1306
Liao J, Seril DN, Lu GG, Zhang M, Toyokuni S, Yang AL, Yang GY (2008) Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice. Mol Carcinogen 47:638–646
Liu BH, Piao XH, Niu W, Zhang QY, Ma C, Wu T, Gu QC, Cui TF, Li SD (2020) Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4-dependent PI3K/AKT/NF-kappa B Oxidative and inflammatory signaling and gut microbiota. Front Pharmacol 11:1036
Luo C, Zhang H (2017) The role of proinflammatory pathways in the pathogenesis of colitis-associated colorectal cancer. Mediators Inflamm 2017:5126048
Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM (2004) TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286:G367-376
Ma X, Hu Y, Li X, Zheng X, Wang Y, Zhang J, Fu C, Geng F (2018) Periplaneta americana ameliorates dextran sulfate sodium-induced ulcerative colitis in rats by keap1/Nrf-2 activation, intestinal barrier function, and gut microbiota regulation. Front Pharmacol 9:944
Morrison G, Headon B, Gibson P (2009) Update in inflammatory bowel disease. Aust Fam Physician 38:956–961
Nguyen T, Chen X, Chai J, Li R, Han X, Chen X, Liu S, Chen M, Xu X (2020) Antipyretic, anti-inflammatory and analgesic activities of Periplaneta americana extract and underlying mechanisms. Biomed Pharmacother 123:109753
Olaiya B, Renelus BD, Filon M, Saha S (2020) Trends in morbidity and mortality following colectomy among patients with ulcerative colitis in the biologic era (2002–2013): a study using the national inpatient sample. Digest Dis Sci. https://doi.org/10.1007/s10620-020-06474-1
Olsen T, Goll R, Cui G, Husebekk A, Vonen B, Birketvedt GS, Florholmen J (2007) Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol 42:1312–1320
Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ (2012) Ulcerative colitis. Lancet 380:1606–1619
Perse M, Cerar A (2012) Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012:718617
Rahmani F, Asgharzadeh F, Avan A, Barneh F, Parizadeh MR, Ferns GA, Ryzhikov M, Ahmadian MR, Giovannetti E, Jafari M, Khazaei M, Hassanian SM (2020) Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-kappaB signaling pathways. Life Sci 249:117470
Rav NH, Panchal HK (2020) Antibiotic susceptibility testing and antimicrobial compound production potential study of bacteria isolated from Periplaneta americana. Mukt Shabd J 9:3519–3528
Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK (2003) Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102:1515–1524
Sham HP, Bazett M, Bosiljcic M, Yang HJ, Luk B, Law HT, Morampudi V, Yu HB, Pankovich J, Sutcliffe S, Bressler B, Marshall JK, Fedorak RN, Chen J, Jones M, Gunn H, Kalyan S, Vallance BA (2018) Immune stimulation using a gut microbe-based immunotherapy reduces disease pathology and improves barrier function in ulcerative colitis. Front Immunol 9:2211
Shi YJ, Hu SJ, Zhao QQ, Liu XS, Liu C, Wang H (2019) Toll-like receptor 4 (TLR4) deficiency aggravates dextran sulfate sodium (DSS)-induced intestinal injury by down-regulating IL6, CCL2 and CSF3. Ann Transl Med 7:713
Singh NP, Singh UP, Singh B, Price RL, Nagarkatti M, Nagarkatti PS (2011) Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of Foxp3 and IL-17 expression and amelioration of experimental colitis. PLoS ONE 6:e23522
Sun Y, Wang ZH, Chi HH, Hu QY, Ye JN, Liu HL, Cheng XB, Shi H, Zhou ZC, Teng JL, Yang CD, Su YT (2019) Elevated serum levels of interleukin-10 in adult-onset Still’s disease are associated with disease activity. Clin Rheumatol 38:3205–3210
Taghipour N, Molaei M, Mosaffa N, Rostami-Nejad M, Aghdaei HA, Anissian A, Azimzadeh P, Zali MRJG, Hfbt B (2016) An experimental model of colitis induced by dextran sulfate sodium from acute progresses to chronicity in C57BL/6: correlation between conditions of mice and the environment. Gastroenterol Hepatol Bed Bench 9:45
Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K (2018) Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol 30:1–10
Thompson AI, Lees CW (2011) Genetics of ulcerative colitis. Inflamm Bowel Dis 17:831–848
Tian T, Wang Z, Zhang J (2017) Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxid Med Cell Longev 2017:4535194
Wang YH, Yang XL, Wang L, Cui MX, Cai YQ, Li XL, Wu YJ (2010) Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats. Can J Physiol Pharmacol 88:888–898
Wang T, Liao Q, Wu Y, Wang X, Fu C, Geng F, Qu Y, Zhang J (2020) A composite hydrogel loading natural polysaccharides derived from Periplaneta americana herbal residue for diabetic wound healing. Int J Biol Macromol 164:3846–3857
Xu XT, Wang YH, Wei ZF, Wei WH, Zhao P, Tong B, Xia YF, Dai Y (2017) Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPAR gamma/AMPK/ACC1 pathway. Cell Death Dis 8:e2723
Xue P, Wang L, Xu J, Liu J, Pan X, Zhao Y, Xu H (2020) Temperature-sensitive hydrogel for rectal perfusion improved the therapeutic effect of Kangfuxin liquid on DSS-induced ulcerative colitis mice: the inflammation alleviation and the colonic mucosal barriers repair. Int J Pharm 589:119846
Yu W, Lu B, Zhang H, Zhang Y, Yan J (2016) Effects of the Sijunzi decoction on the immunological function in rats with dextran sulfate-induced ulcerative colitis. Biomed Rep 5:83–86
Zhang M, Deng CS, Zheng JJ, Xia J (2006) Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis. Acta Pharmacol Sin 27:1071–1077
Zhang F, Ma N, Gao YF, Sun LL, Zhang JG (2017) Therapeutic effects of 6-gingerol, 8-gingerol, and 10-gingerol on dextran sulfate sodium-induced acute ulcerative colitis in rats. Phytother Res 31:1427–1432
Zhao Y, Yang A, Tu P, Hu Z (2017) Anti-tumor effects of the American cockroach. Periplaneta Americana Chin Med 12:26
Zhu L, Gu P, Shen H (2019) Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats. Int Immunopharmacol 68:242–251
Acknowledgements
This work was supported by the National Natural Science Foundation of China (NO. 81860742, 82060780, 81672305), Yunnan Fundamental Research Projects (2019FH001-003, 202001AT070021), and Innovative Team of Dali University for Digital Development of Medicinal Insects and Arachnids Resources (NO. ZKLX2020303).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors have no conflicts of interest in this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ni, L., Lu, Q., Tang, M. et al. Periplaneta americana extract ameliorates dextran sulfate sodium-induced ulcerative colitis via immunoregulatory and PI3K/AKT/NF-κB signaling pathways. Inflammopharmacol 30, 907–918 (2022). https://doi.org/10.1007/s10787-022-00955-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-022-00955-7